0
0

Cart (0)

Home > Isotope Labelled Standards > Vilazodone

Vilazodone - Isotope Labelled Standards

Vilazodone metabolite
Wishlist
Select options

Vilazodone metabolite-10

  • CAT Number DCTI-A-238
  • CAS Number 163521-19-5
  • Molecular Formula C26H26N4O3
  • Molecular Weight 442.52
Select options
Wishlist
Vilazodone impurity
Wishlist
Select options

Vilazodone Metabolite 11

  • CAT Number DCTI-A-225
  • CAS Number NA
  • Molecular Formula C26H27N5O3
  • Molecular Weight 457.53
Select options
Wishlist
References
FAQ's

References

  1. Boettcher, Henning; Seyfried, Christoph; Bartoszyk, Gerd; Greiner, Hartmut, Piperdine and piperazine derivatives which affect the C.N.S., Merck Patent G.m.b.H., Germany, EP648767B1, May 28, 1997
  2. El-Bagary, Ramzia; Hashem, Hanaa; Fouad, Marwa; Tarek, Sally, UPLC-MS-MS method for the determination of vilazodone in human plasma: application to a pharmacokinetic study, Journal of Chromatographic Science, Volume: 54, Issue: 8, Pages: 1365-1372, 2016
 

Frequently Asked Questions

Controlling impurities in Vilazodone is crucial to ensure the drug’s quality, safety, and efficacy. They can affect Vilazodone stability, pharmacological activity, and toxicity and interfere with the analytical methods used for its detection and quantification.

Regulatory agencies like the US FDA, EMA, and ICH establish acceptable limits for impurities in Vilazodone. The limits may vary depending on the impurities ensuring that Vilazodone meets stringent standards for its quality and suitability for patient use.

Impurities in Vilazodone are controlled during the synthetic process by implementing good manufacturing practices (GMP) and using appropriate analytical methods for impurity identification and quantification.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart